Merck Signs Business Transfer Agreement With Its Subsidiary
2018-06-21 Merger and Acquisitions Drugs & Pharmaceuticals Western India
Merck Limited has entered into a business transfer agreement (BTA ) with Merck Life Science Private Limited (MLSPL) for the transfer of the Company's biopharma (BP), performance materials (PM) and life science (LS) businesses to MLSPL and/or its affiliates. Pursuant to and in connection therewith, the Company has also entered into an agreement with MLSPL, Merck Specialities Private Limited (MSPL) and Merck Performance Materials Private Limited (MPMPL) for the said direct transfer of the BP and PM businesses to MSPL and MPMPL respectively, in accordance with the terms and conditions of the BT A. MSPL and MPMPL are affiliates of MLSPL, all three entities being subsidiaries of the Company's ultimate holding company, Merck KGaA, Dannstadt, Germany. The completion of the business transfer under the aforementioned agreements is subject to certain closing conditions including receipt of regulatory approvals.